Yangxi Liu

454 total citations · 1 hit paper
11 papers, 292 citations indexed

About

Yangxi Liu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Biological Psychiatry. According to data from OpenAlex, Yangxi Liu has authored 11 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Biological Psychiatry. Recurrent topics in Yangxi Liu's work include Gut microbiota and health (4 papers), Tryptophan and brain disorders (3 papers) and Heart Failure Treatment and Management (3 papers). Yangxi Liu is often cited by papers focused on Gut microbiota and health (4 papers), Tryptophan and brain disorders (3 papers) and Heart Failure Treatment and Management (3 papers). Yangxi Liu collaborates with scholars based in China. Yangxi Liu's co-authors include Zhihua Yang, Chongming Wu, Zhenzhen Li, Lin Wang, Qingchun Wang, Yuhang Zhang, Shanshan Lin, Lu Chen, Yi Wang and Zehui Guo and has published in prestigious journals such as Industrial & Engineering Chemistry Research, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Yangxi Liu

10 papers receiving 285 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota and hypertension: association, mechanisms and treatment

2023 96 citations Zhihua Yang, Qingchun Wang et al. Clinical and Experimental Hypertension profile →

Peers

Yangxi Liu

MB

PHYSI

IMMUN

BP

GENET

Yi Lasanajak United States

Shiyao Feng China

Ruining Xie China

Jin‐Shan Feng China

Rongxuan Hua China

Chunmei Lv China

Aleksandra Tarasiuk Poland

Seiji Yokoi Japan

Leire Virto Spain

Yi Lasanajak United States

Yangxi Liu

257 ×1.6

MB

102 ×1.4

PHYSI

26 ×0.6

IMMUN

41 ×1.1

BP

26 ×0.8

GENET

Citations per year, relative to Yangxi Liu Yangxi Liu (= 1×) peers Yi Lasanajak

Countries citing papers authored by Yangxi Liu

Since Specialization

Citations

This map shows the geographic impact of Yangxi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangxi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangxi Liu more than expected).

Fields of papers citing papers by Yangxi Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangxi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangxi Liu. The network helps show where Yangxi Liu may publish in the future.

Co-authorship network of co-authors of Yangxi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yangxi Liu. A scholar is included among the top collaborators of Yangxi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangxi Liu. Yangxi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Su, Yu, Rong Fan, Jiabao Li, et al.. (2024). Interfacial Au^δ−–O_V–Ti Structure Promoted C–H Bond Activation for Selective Oxidation of Fatty Alcohols to Fatty Acids. Industrial & Engineering Chemistry Research. 63(30). 13115–13126. 3 indexed citations

2.

Yang, Zhihua, Lin Wang, Yangxi Liu, et al.. (2023). Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms. Frontiers in Pharmacology. 14. 1154167–1154167. 7 indexed citations

3.

Lin, Shanshan, Zhihua Yang, Yangxi Liu, et al.. (2023). Risk Prediction Models and Novel Prognostic Factors for Heart Failure withPreserved Ejection Fraction: A Systematic and Comprehensive Review. Current Pharmaceutical Design. 29(25). 1992–2008.

4.

Yang, Zhihua, Yangxi Liu, Rui Chen, et al.. (2023). Gut microbiota: A new target of traditional Chinese medicine for insomnia. Biomedicine & Pharmacotherapy. 160. 114344–114344. 49 indexed citations

5.

Yang, Zhihua, Shanshan Lin, Yangxi Liu, et al.. (2023). Targeting intestinal microecology: potential intervention strategies of traditional Chinese medicine for managing hypertension. Frontiers in Pharmacology. 14. 1171119–1171119. 6 indexed citations

6.

Liu, Yangxi, et al.. (2023). Targeting mitochondrial circadian rhythms: The potential intervention strategies of Traditional Chinese medicine for myocardial ischaemia‒reperfusion injury. Biomedicine & Pharmacotherapy. 166. 115432–115432. 5 indexed citations

7.

Yang, Zhihua, Yangxi Liu, Zhenzhen Li, et al.. (2023). Coronary microvascular dysfunction and cardiovascular disease: Pathogenesis, associations and treatment strategies. Biomedicine & Pharmacotherapy. 164. 115011–115011. 12 indexed citations

8.

Yang, Zhihua, Qingchun Wang, Yangxi Liu, et al.. (2023). Gut microbiota and hypertension: association, mechanisms and treatment. Clinical and Experimental Hypertension. 45(1). 2195135–2195135. 96 indexed citations breakdown →

9.

Yang, Zhihua, Shanshan Lin, Yangxi Liu, et al.. (2022). A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization. Frontiers in Pharmacology. 13. 999179–999179. 60 indexed citations

10.

Yang, Zhihua, Yangxi Liu, Lin Wang, et al.. (2022). Traditional Chinese medicine against COVID-19: Role of the gut microbiota. Biomedicine & Pharmacotherapy. 149. 112787–112787. 42 indexed citations

11.

Lin, Shanshan, Yangxi Liu, Yawen Cao, et al.. (2021). Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology. 12. 659707–659707. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact